You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD34 cells mobilization

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Fanconi Anemia Trial in Paris (G-CSF, Plerixafor)

Completed
  • Fanconi Anemia
  • Paris, France
    Hôpital necker-Enfants malades
Dec 20, 2021

Sickle Cell Disease Trial in New York (Plerixafor)

Recruiting
  • Sickle Cell Disease
  • New York, New York
  • +1 more
Mar 21, 2022

Stable Coronary Artery Disease Trial in Pavia (Atorvastatin)

Terminated
  • Stable Coronary Artery Disease
  • Pavia, Italy
    Fondazione Irccs Policlinico San Matteo
Aug 30, 2021

Primary Mitochondrial Diseases Trial in Ramat Gan (Bone Marrow mobilization, Apheresis, MNV-BM-PLC infusion)

Not yet recruiting
  • Primary Mitochondrial Diseases
  • Bone Marrow mobilization
  • +2 more
  • Ramat Gan, Israel
    Sheba Medical Center - Tel Ashomer
Aug 30, 2021

Lymphoma, Peripheral Blood Stem Cell Transplantation Trial (Eltrombopag olamine)

Not yet recruiting
  • Lymphoma
  • Peripheral Blood Stem Cell Transplantation
  • Eltrombopag olamine
  • (no location specified)
Jul 25, 2023

Fanconi Anemia Trial in Barcelona, Madrid (filgrastim, plerixafor)

Completed
  • Fanconi Anemia
  • Barcelona, Spain
  • +1 more
May 25, 2020

Sickle Cell Disease Trial in Saint Louis (Motixafortide, Natalizumab, Leukapheresis)

Not yet recruiting
  • Sickle Cell Disease
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 8, 2022

Mitochondrial Diseases, Pearson Syndrome Trial in Ramat Gan (MNV-201)

Recruiting
  • Mitochondrial Diseases
  • Pearson Syndrome
  • MNV-201
  • Ramat Gan, Israel
    Sheba Medical Center
Aug 24, 2023

Severe Aplastic Anemia, MDS (Myelodysplastic Syndrome) Trial in Baltimore, Bethesda, Minneapolis (Miltenyi CD34 Reagent System,

Recruiting
  • Severe Aplastic Anemia
  • MDS (Myelodysplastic Syndrome)
  • Miltenyi CD34 Reagent System
  • Donor derived G-CSF mobilized PBC
  • Baltimore, Maryland
  • +2 more
Jan 25, 2023

Sickle Cell Disease Trial in Paris (DREPAGLOBE drug product)

Active, not recruiting
  • Sickle Cell Disease
  • DREPAGLOBE drug product
  • Paris, France
    Department of Biotherapy, Necker-Enfants Malades Hospital
Sep 26, 2022

AML, ALL, Lymphoid Malignancies Trial in Birmingham (Infusion of CD34 selected hematopoietic stem cells)

Not yet recruiting
  • AML
  • +5 more
  • Infusion of CD34 selected hematopoietic stem cells
  • Birmingham, Alabama
    University of Alabama at Birmingham
Sep 14, 2023

Hematologic Disorders Trial in Aurora (Miltenyi CliniMACS® CD34 Reagent System)

Recruiting
  • Hematologic Disorders
  • Miltenyi CliniMACS® CD34 Reagent System
  • Aurora, Colorado
    University of Colorado
Feb 22, 2022

Chronic Myeloid Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Atlanta (G-CSF mobilized CD34+ selected

No longer available
  • Chronic Myeloid Leukemia
  • +2 more
  • G-CSF mobilized CD34+ selected cells for transplantation
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Feb 28, 2022

Retinitis Pigmentosa Trial in Sacramento (Intravitreal autologous CD34+ cells)

Recruiting
  • Retinitis Pigmentosa
  • Intravitreal autologous CD34+ cells
  • Sacramento, California
    University of California Davis
Sep 1, 2022

ß-thalassemia Trial (BD211)

Not yet recruiting
  • β-thalassemia
  • BD211
  • (no location specified)
Mar 15, 2023

ß-thalassemia Trial in Shanghai (BD211)

Not yet recruiting
  • β-thalassemia
  • BD211
  • Shanghai, China
    Shanghai Ruijin Hospital
Mar 16, 2023

B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • Cyclophosphamide injection
  • +2 more
  • Charleston, South Carolina
    Hollings Cancer Center at Medical University of South Carolina
Jan 18, 2023

Apheresis of Patients With Immunodeficiency

Recruiting
  • LAD-1
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    CD34 + Stem Cells and Biological Markers of Angiogenesis in

    Recruiting
    • Vasculopathy
    • Heart Transplant Failure
    • coronary CT angiography
    • Ljubljana, Slovenia
      Advanced Heart Failure and Transplantation Center, University Me
    Aug 2, 2022

    Mucopolysaccharidosis II Trial (Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII)

    Not yet recruiting
    • Mucopolysaccharidosis II
    • Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII
    • (no location specified)
    Dec 16, 2022

    Non-exudative Age-related Macular Degeneration, Diabetic Retinopathy, Retina Vein Occlusion Trial in Sacramento (CD34+ bone

    Enrolling by invitation
    • Non-exudative Age-related Macular Degeneration
    • +4 more
    • CD34+ bone marrow stem cells intravitreal
    • Sacramento, California
      University of California Davis
    Aug 8, 2022

    Hiv Trial in Philadelphia (Autologous CD4 T-Cells)

    Completed
    Has Results
    • Hiv
    • Autologous CD4 T-Cells
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Nov 13, 2022

    Adenosine Deaminase Severe Combined Immune Deficiency Trial (A cryopreserved formulation of autologous mPB CD34+ hematopoietic

    Not yet recruiting
    • Adenosine Deaminase Severe Combined Immune Deficiency
    • A cryopreserved formulation of autologous mPB CD34+ hematopoietic stem and progenitor cells transduced ex vivo with the EFS-ADA lentiviral vector encoding the human ADA enzyme
    • (no location specified)
    Jun 20, 2022

    Sickle Cell Disease Trial in Birmingham, Palo Alto, Saint Louis (GPH101 Drug Product)

    Active, not recruiting
    • Sickle Cell Disease
    • GPH101 Drug Product
    • Birmingham, Alabama
    • +2 more
    Jan 5, 2023

    Crohn's Disease Trial in Pittsburgh (autologous CD34-selected peripheral blood stem cells transplant, Alemtuzumab, ATG)

    Recruiting
    • Crohn's Disease
    • autologous CD34-selected peripheral blood stem cells transplant
    • +8 more
    • Pittsburgh, Pennsylvania
    • +1 more
    Feb 9, 2022